Sign in
4/A

Changes in Ownership

Attovia Therapeutics, Inc. Filed Acc 0001644888-26-000009

Options or other derivatives

  • President and CEO acquired 538,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Fu Tao President and CEO 2026-08-04 Grant or award · Stock Option (Right to Buy) +538,300 538,300 D
Loading xslF345X06/form4a-10092026_121054.xml…